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Abstract 
Bacterial resistance to antibiotics is an increasing threat to global healthcare systems. We therefore sought compounds with 
potential to reverse antibiotic resistance in a clinically relevant multi-drug resistant isolate of Escherichia coli (NCTC 13400). 
200 natural compounds with a history of either safe oral use in man, or as a component of a traditional herb or medicine, 
were screened. Four compounds; ellagic acid, propyl gallate, cinchonidine and cepharanthine, lowered the minimum inhibi-
tory concentrations (MICs) of tetracycline, chloramphenicol and tobramycin by up to fourfold, and when combined up to 
eightfold. These compounds had no impact on the MICs of ampicillin, erythromycin or trimethoprim. Mechanistic studies 
revealed that while cepharanthine potently suppressed efflux of the marker Nile red from bacterial cells, the other hit com-
pounds slowed cellular accumulation of this marker, and/or slowed bacterial growth in the absence of antibiotic. Although 
cepharanthine showed some toxicity in a cultured HEK-293 mammalian cell-line model, the other hit compounds exhibited 
no toxicity at concentrations where they are active against E. coli NCTC 13400. The results suggest that phytochemicals 
with capacity to reverse antibiotic resistance may be more common in traditional medicines than previously appreciated, 
and may offer useful scaffolds for the development of antibiotic-sensitising drugs.
 * Clett Erridge 
 clett.erridge@aru.ac.uk
1 School of Life Sciences, Anglia Ruskin University, East 
Road, Cambridge CB1 1PT, UK
2 Diabetes Research Centre, University of Leicester, Leicester 
General Hospital, Gwendolen Road, Leicester LE5 4PW, UK
3 Department of Health Sciences, University of Leicester, 
University Rd, Leicester LE1 7RH, UK
 D. Jenic et al.
1 3
Graphic Abstract
Keywords Antibiotic resistance · Natural products · Phytochemical · Screening · Efflux pump inhibitor
1 Introduction
Gram-negative bacteria displaying resistance to multiple 
classes of antibiotics are increasingly prevalent and dif-
ficult to treat in modern healthcare systems [1]. Histori-
cally, this issue has been countered by the discovery and 
development of new classes of antibiotics. However, as 
only two new classes of antibiotic have been discovered 
since the 1960s, attention has focussed more recently on 
the identification of agents which target bacterial mecha-
nisms of resistance [2, 3].
This approach has proven successful for the restora-
tion of utility of some β-lactam antibiotics via lactamase 
inhibitors, such as clavulanic acid [3]. Some success has 
also been reported in the identification of compounds with 
capacity to reverse resistance to various non-lactam antibi-
otics in Gram-positive bacteria, particularly Staphylococ-
cus aureus [4, 5]. However, resistance reversal in Gram 
negative bacteria has proven significantly more challeng-
ing, and comparatively little progress has been made in 
identifying novel agents with sensitising properties [6].
We therefore sought to identify compounds with capac-
ity to reverse resistance to six antibiotics of different 
classes using a multi-drug-resistant Escherichia coli. Our 
strategy was based on the hypothesis that since plants have 
successfully countered the threat of Gram-negative infec-
tion for millennia through their production of antibacte-
rial secondary metabolites, it is likely that they have also 
faced the issue of resistance to these defences via the same 
resistance mechanisms currently posing a threat to man. 
This raises the possibility that plant secondary metabolites 
with potential to combat bacterial resistance mechanisms 
may have also co-evolved in parallel with compounds with 
direct bactericidal or bacteriostatic properties, and may 
therefore have potential as scaffolds for the development 
of novel classes of therapeutic resistance-reversing drugs.
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As small molecules intended for clinical use should also 
be of low toxicity in mammalian systems, and ideally with 
potential for rapid translation to human trials, we chose to 
focus only on compounds isolated from plants with a history 
of use in man as traditional herbs or medicines. A natural 
product library comprising 200 such phytochemicals was 
therefore screened to identify compounds with capacity to 
reverse resistance using the model multi-drug resistant E. 
coli isolate NCTC 13400. Potential mechanisms for the sen-
sitising properties of the hit compounds, and their impacts 
on the viability of mammalian cells cultured in vitro, were 
then explored.
2  Results and Discussion
2.1  Primary Screen of 200 Natural Compounds 
for Reversal of Resistance to Tetracycline
At least four major mechanisms are currently thought to 
mediate bacterial resistance to antibiotics; namely drug 
destruction, efflux pumps, target modification and reduced 
permeability of the cell wall. Although some success has 
been achieved in the development of drugs with capacity 
to reverse resistance via the first of these mechanisms (i.e. 
β-lactamase inhibitors), comparatively little progress has 
been made in the discovery of molecules with the capacity to 
block other forms of resistance, and sensitise to other classes 
of antibiotic, particularly in Gram-negative bacteria [1, 3].
Plants have faced millennia of exposure to Gram-neg-
ative pathogens, many of which are likely to have evolved 
diverse resistance mechanisms to counter bacteriostatic or 
bactericidal plant compounds [7, 8]. As plants may have also 
faced selection in turn to develop phytochemical secondary 
metabolites targeting such mechanisms of resistance, we 
hypothesised that screening a natural product library may 
offer potential leads for resistance reversing agents.
The library screened in the present study contains sev-
eral compounds of natural origin that are used as antibiot-
ics, and three of these (chloramphenicol, doxycycline and 
rifampicin) fully prevented growth of E. coli NCTC 13400 
at 100 μM, in the presence or absence of 0.25× minimum 
inhibitory concentration (MIC) tetracycline (Fig. 1a). None 
of the non-antibiotic compounds tested achieved the same 
level of inhibition at the 21 h timepoint. However, a closer 
inspection of the data from earlier timepoints indicated that 
several compounds slowed growth to a greater extent in the 
presence of tetracycline than without, suggesting potential 
for resistance reversal (Fig. 1b). The four compounds that 
scored the highest according to this metric (after exclusion 
of existing antibiotics) were cepharanthine, cinchonidine, 
ellagic acid and propyl gallate.
Checkerboard assays then showed that each of these com-
pounds reduced the MIC of tetracycline by up to twofold at 
both the 8 and 21 h timepoints (Fig. 2). We hypothesised that 
the hit compounds may exhibit synergistic or additive effects 
on resistance reversal, so a mixture of the 4 phytochemicals 
together (at 64 μM each) was also tested, and this reduced the 
MIC of tetracycline by fourfold at both timepoints (Table 1).
2.2  Effects of Hit Compounds on Sensitivity of E. coli 
NCTC 13400 to Other Antibiotics
The four hit compounds had no impact on the MICs 
of ampicillin, erythromycin or trimethoprim (Fig.  3). 
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Fig. 1  Primary screen of 200 phytochemicals for capacity to reverse 
tetracycline resistance in E. coli NCTC 13400. E. coli NCTC 
13400 was cultured in microtitre plates in the presence or absence 
of 0.25× MIC (16  μg/mL) tetracycline with 100  μM of each phyto-
chemical, or vehicle control (1% DMSO). Absorbance at 600 nm was 
measured at 21 h (a) and 5 h (b). Each individual point represents one 
of the tested phytochemicals. Hit compounds chosen for further study 
are highlighted
 D. Jenic et al.
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However, the MIC of chloramphenicol was reduced two-
fold by cepharanthine and cinchonidine, and fourfold 
by ellagic acid. Propyl gallate also reduced the MIC of 
tobramycin by twofold, at 21 h (Table 2). A mixture of the 
4 phytochemicals together (at 64 μM each) did not impact 
on the MICs of ampicillin, erythromycin or trimethoprim, 
but lowered the MIC of tetracycline by fourfold, chloram-
phenicol by eightfold and tobramycin by fourfold. Disc 
diffusion assays using each antibiotic or mixture revealed 
a similar, although less pronounced, pattern of sensitisa-
tion (Table 3).
Two of the top four hits from the present study, or their 
close derivatives, have been reported previously to exhibit 
antibiotic potentiating effects. Ellagic acid was reported to 
potentiate the antibiotics novobiocin, coumermycin, chloro-
biocin, rifampicin and fusidic acid in Acinetobacter baumannii 
[9]. Gallic acid, which is structurally similar to propyl gallate, 
was also shown to potentiate the activities of sulfamethoxazole 
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Fig. 2  Checkerboard assays of the top four hits from the primary 
screen. E. coli NCTC 13400 was cultured in the presence of doubling 
dilutions of tetracycline, in combination with doubling dilutions of 
cepharanthine (a), cinchonidine (b), ellagic acid (c) propyl gallate 
(d), or vehicle control (DMSO). Absorbance was measured at 600 nm 
at 21 h. Means of three independent experiments ± SD are shown
Table 1  MICs and  IC50 of 
tetracycline in the presence 
of maximal inhibitory 
concentrations of each 
phytochemical
Calculations are based on a phytochemical concentration of 256 μM, except for ellagic acid, which repro-
ducibly exhibited maximal inhibition at 64 μM. MIC and  IC50 concentrations are given in μg/mL tetracy-
cline
a The 4 chemical mix comprises cepharanthine, cinchonidine, ellagic acid and propyl gallate at 64 µM each
*P-values indicate comparisons of  IC50 values of three independent experiments at 21 h with vehicle alone 
(2.56% DMSO) by ANOVA with Dunnett’s post test
MIC (8 h) MIC (21 h) IC50 (8 h) IC50 (21 h) P-value*
DMSO 32 64 15.52 25.2 –
Cepharanthine 16 32 6.91 16.0 0.0126
Cinchonidine 16 32 8.80 22.6 0.6840
Ellagic acid 16 32 8.91 15.9 0.0082
Propyl gallate 16 32 6.67 15.4 0.0038
Mix (4 chemical)a 8 16 4.05 6.1 < 0.0001
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and tetracycline in Pseudomonas aeruginosa [10]. However, 
to our knowledge, no sensitising properties of cepharanthine 
or cinchonidine have been reported previously.
2.3  Potential Mechanisms of Action of Hit 
Phytochemicals
Because the hit compounds lowered the MICs of antibiot-
ics from several different classes, we hypothesised that 
they may act at least partly as inhibitors of multidrug 
efflux systems. To test this, we first measured accumula-
tion of the lipophilic dye Nile red using E. coli NCTC 
13400 cells. Cepharanthine markedly accelerated cellular 
uptake of this dye, consistent with inhibition of efflux, 
while the other hit compounds and mixtures consistently 
reduced dye accumulation compared to vehicle control 
(Fig. 4a). Efflux assays then confirmed that cepharanthine 
markedly inhibited efflux of Nile red from loaded cells, 
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Fig. 3  Effects of top hits on sensitivity of E. coli NCTC 13400 to 
other antibiotics. E. coli NCTC 13400 was cultured for 21  h in the 
presence of 64  μM of each phytochemical, vehicle control (0.64% 
DMSO), and indicated concentrations of ampicillin (a), chloram-
phenicol (b), erythromycin (c), tobramycin (d), or trimethoprim (e). 
Absorbance at 600 nm was measured at 21 h. Means of three inde-
pendent experiments ± SD are shown. Abbreviations: Ellagic acid 
(Ell), cepharanthine (Cep), cinchonidine (Cin), propyl gallate (Pro), 
mix of all 4 phytochemicals (Mix4)
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while the other hit compounds and mixtures had little 
impact on this pathway (Fig. 4b).
We next tested the hypothesis that the hit compounds 
may limit cellular metabolism or availability of energy, 
since these may contribute to resistance mechanisms. In 
the absence of antibiotics, ellagic acid and propyl gal-
late both markedly slowed the rate of growth of the test 
strain, while cepharanthine and cinchonidine had little or 
no impact on growth rate (Fig. 4c). To test whether the 
reversal of resistance may be specific to E. coli NCTC 
13400, the effects of each phytochemical on antibiotic sen-
sitivity were re-examined using the E. coli strain DH5-α, 
which lacks pEK499 and resistance to the tested antibiot-
ics. While ellagic acid generally sensitised this strain to 
most antibiotics to a similar degree to that observed in E. 
coli NCTC 13400, the other compounds were largely inef-
fective at reversing resistance to the tested antibiotics in 
DH5-α (Table 4). In the absence of antibiotics, ellagic acid 
and propyl gallate had a greater impact on the growth rate 
of E. coli DH5-α than cepharanthine and cinchonidine, but 
the degree of inhibition was not as pronounced as that seen 
in E. coli NCTC 13400 (Fig. 4d).
Taken together, these findings suggest that cepharanthine 
likely mediates its sensitising effects at least partly via its 
action as an efflux pump inhibitor (EPI), since this com-
pound both accelerated accumulation of Nile red and slowed 
its efflux from bacterial cells. Notably, although numerous 
natural EPIs for Gram-positive bacteria have been described 
[4, 11], very few have been reported for Gram-negative bac-
teria [2]. Two of the best known examples of such molecules 
are artesunate, which inhibits AcrAB-TolC in E. coli [12], 
and berberine, which inhibits MexXY-OprM in P. aerugi-
nosa [13]. Interestingly, both of these compounds are present 
in the library, but they did not score well for the primary 
phenotypic endpoint of tetracycline resistance reversal, rank-
ing in 156th, and 65th places, respectively. Further experi-
ments revealed that neither of these compounds inhibits 
efflux of Nile red from E. coli NCTC 13400 (Fig. 4e). Thus, 
EPI activity against RND type pumps, such as MexXY-
OprM and AcrAB-TolC, may not necessarily be a strong 
indicator of potential to reverse resistance to tetracycline. It 
is also notable that while artesunate is a proven inhibitor of 
the AcrAB-TolC system in E. coli [12], it did not sensitise to 
tetracycline in our assays. Taken together, these data suggest 
Table 2  Effects of hit 
phytochemicals on sensitivity 
of E. coli NCTC 13400 to 
antibiotics of other classes
Dose curves of each antibiotic were supplemented with 64 μM of each phytochemical, and MICs were cal-
culated from A600 measured at 21 h. MIC concentrations are given in μg/mL
a The 4 chemical mix comprises cepharanthine, cinchonidine, ellagic acid and propyl gallate at 64 µM each
b The 3 chemical mix comprises cinchonidine, ellagic acid and propyl gallate at 64 µM each
Ampicillin Chloram-
phenicol
Erythromycin Tobramycin Trimethoprim
DMSO > 256 8 > 256 64 > 256
Cepharanthine > 256 4 > 256 64 > 256
Cinchonidine > 256 4 > 256 64 > 256
Ellagic acid > 256 2 > 256 64 > 256
Propyl gallate > 256 8 > 256 32 > 256
Mix (4 chemical)a > 256 1 > 256 16 > 256
Mix (3 chemical)b > 256 1 > 256 32 > 256
Table 3  Disk diffusion assays of the effects of hit phytochemicals on antibiotic sensitivity in E. coli NCTC 13400
Zones of clearance are presented as millimetres diameter ± SD (NI = no inhibition). Paper discs were 6 mm in diameter, containing 50 μg antibi-
otic per disc (except chloramphenicol, which was 1 μg per disc), and 50 nmol of respective individual phytochemicals
a The 4 chemical mix comprises cepharanthine, cinchonidine, ellagic acid and propyl gallate at 12.5 nmol each
*P < 0.05, **P < 0.01, ANOVA with Dunnett’s test vs DMSO control. n = 3–4 independent experiments
Ampicillin Chloramphenicol Erythromycin Tetracycline Tobramycin Trimethoprim
DMSO NI 20.3 ± 0.6 NI 10.0 ± 0.0 14.0 ± 0.8 NI
Cepharanthine NI 20.7 ± 1.2 NI 10.0 ± 0.0 14.8 ± 1.5 NI
Cinchonidine NI 21.7 ± 1.5 NI 10.5 ± 1.0 15.5 ± 1.7 NI
Ellagic acid NI 24.0 ± 0.0** NI 11.0 ± 1.2 15.3 ± 2.2 NI
Propyl gallate NI 23.7 ± 0.6** NI 13.0 ± 0.8** 18.0 ± 1.8* NI
Mix (4 chemical)a NI 22.7 ± 1.2* 7.0 ± 1.2 10.3 ± 0.5 15.5 ± 1.3 NI
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Fig. 4  Effects of phytochemicals on uptake and efflux of Nile red in 
E. coli NCTC 13400. For Nile red accumulation assays (a), E. coli 
NCTC 13400 was cultured with 64  μM of each phytochemical or 
vehicle control (0.64% DMSO). After 2 min, 5 μM of the marker Nile 
red was added. For efflux assays (b), CCCP de-energised cells were 
pre-loaded with Nile red, and re-energised after 2 min with 50 mM 
glucose. In both cases, fluorescence at 620 nm, which is proportional 
to cellular content of Nile red, was measured every 5 s for indicated 
periods. The kinetics of bacterial growth in the absence of antibiot-
ics were also assayed by measuring absorbance at 600 nm for E. coli 
NCTC 13400 (c) or E. coli DH5-α (d), in the presence of 64 μM of 
each phytochemical, or vehicle control (0.64% DMSO). The effects of 
cepharanthine, artesunate and berberine (64 µM) on efflux were com-
pared with 50 µM CCCP (a positive control for efflux inhibition) in E. 
coli NCTC 13400 (e). Results are representative of at least three inde-
pendent experiments. Abbreviations: Ellagic acid (Ell), cepharanthine 
(Cep), cinchonidine (Cin), propyl gallate (Pro), mix of all 4 phyto-
chemicals (Mix4), mix of Ell, Cin and Pro only (Mix3)
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that cepharanthine, and the other hits from the present study, 
are not likely to reverse tetracycline resistance by acting as 
EPIs for AcrAB-TolC [14].
It is also interesting to note that cepharanthine was 
reported previously to exhibit EPI activity in cultured mam-
malian cells, by inhibiting the human P-glycoprotein multi-
drug efflux pump [15]. This raises the possibility that the tar-
get of cepharanthine activity in E. coli may exhibit structural 
similarity with P-glycoprotein, which is a member of the 
ATP-binding cassette (ABC)-family of efflux pumps. How-
ever, although there are many predicted examples of ABC 
type pumps in the E. coli genome [16], no such pumps of 
this class are represented on the pEK-499 plasmid [17]. The 
TetA efflux system, which confers the tetracycline resistance 
provided by this plasmid, is a member of the structurally 
distinct major facillitator family of efflux pumps [2]. We note 
that E. coli DH5-α, which lacks the TetA efflux system, was 
not sensitised to tetracycline by cepharanthine. However, 
further studies will be required to ascertain more definitively 
whether the TetA system is a target of cepharanthine EPI 
activity.
As the other hit compounds did not inhibit Nile red efflux, 
it is likely that their sensitising properties are conferred via 
other mechanisms. One possibility is that, as some resist-
ance mechanisms are relatively energy-intensive [18], agents 
which non-specifically reduce the availability of energy or 
nutrients could inhibit such mechanisms. Notably, both 
ellagic acid and propyl gallate reduced the growth rate of E. 
coli NCTC 13400 and E. coli DH5-α in the absence of anti-
biotics. However, further studies will be required to explore 
this possibility and the mechanism of action of cinchonidine, 
since this compound had little or no impact on growth in 
either strain.
2.4  Effects of Hit Compounds on the Viability 
of Cultured Mammalian Cells
To gain preliminary insight into the potential impact of the 
hit compounds on viability of mammalian cells, MTT assays 
using the HEK-293 (human embryonic kidney) cell line were 
performed in vitro. Although there was no significant impact 
of cinchonidine, ellagic acid or propyl gallate on cell viabil-
ity up to 128 μM, cepharanthine exhibited toxicity with an 
IC50 of 24.6 μM (Fig. 5). The mixture of 4 phytochemicals 
also showed some toxicity at the highest dose tested, pre-
sumably due to content of cepharanthine. A mixture of the 3 
non-toxic phytochemicals, lacking cepharanthine, was there-
fore tested, and this mixture showed no effect on viability in 
this assay at up to 32 μM of each compound. Retesting the 3 
compound mixture in the E. coli sensitisation assays showed 
that it had the same effect as the 4 compound mixture on the 
MICs of the tested antibiotics, except for tobramycin, for 
which sensitivity was increased by only twofold, rather than 
fourfold for the 4 compound mixture (Table 2).
Low toxicity in mammalian systems is a key property of 
any compound intended for use as a scaffold for drug devel-
opment. It is promising to note that in our HEK-293 system, 
ellagic acid, cinchonidine and propyl gallate exhibited no 
toxicity at concentrations up to 128 μM. This is consistent 
Table 4  Effects of hit 
phytochemicals on antibiotic 
sensitivity of E. coli DH5-α
Dose curves of each antibiotic were supplemented with 64 μM of each phytochemical, and MICs (shown 
above in μg/mL) were calculated from A600 measured at 21 h
Ampicillin Chloram-
phenicol
Erythromycin Tetracycline Tobramycin Trimethoprim
DMSO 4 4 128 2 16 0.5
Cepharanthine 4 4 128 2 16 1
Cinchonidine 2 4 128 2 16 1
Ellagic acid 2 2 64 1 32 1
Propyl gallate 4 4 128 1 16 2
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Fig. 5  Effects of hit phytochemicals on viability of human HEK-293 
cells cultured in  vitro. HEK-293 cells were cultured at 2 × 104 cells 
per well of 96-well plates. After 24  h, cells were treated with indi-
cated concentrations of each phytochemical or DMSO control, and 
viability was quantified by MTT assay after a further 24 h. Concen-
trations are given as total phytochemical content for the mixtures. 
Means of three independent experiments ± SD are shown. Abbre-
viations: Ellagic acid (Ell), cepharanthine (Cep), cinchonidine (Cin), 
propyl gallate (Pro), mix of all 4 phytochemicals (Mix4), mix of Ell, 
Cin and Pro only (Mix3)
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with the established use of ellagic acid and propyl gallate as 
approved food additives in various territories. Dietary stud-
ies in man have also confirmed that doses of up to 500 mg 
pure ellagic acid are well tolerated with no obvious side 
effects, and the molecule can reach micromolar concentra-
tions in serum following oral supplementation [19]. Cin-
chonidine is also likely to be of relatively low toxicity, as 
it is isolated from the bark of the medicinal plant Cinchona 
officinalis, which has been used to treat fever and malaria 
for centuries. The low toxicity of these hits supports the 
hypothesised advantage of screening compounds isolated 
from traditional medicines, and lends further weight to ear-
lier observations that such compounds are likely to exhibit 
lower toxicity, and greater ease of translation to trials, than 
purely synthetic compounds, both of which were key objec-
tives of the present study [20].
Nevertheless, we recognise that cepharanthine exhibited 
significant toxicity in our HEK-293 system at doses neces-
sary to enhance antibiotic activity. It is possible that this tox-
icity may relate directly to its activity as an EPI, as numerous 
attempts have been made to use inhibitors of human multi-
drug efflux pumps to reverse chemotherapy resistance of 
tumours in clinical trials. To date, such trials have typically 
failed due to excessive toxicity of the EPI used, suggesting 
that inhibition of certain efflux pumps (such as P-glycopro-
tein, which is a proven target of cepharanthine [15]), may be 
inherently toxic to some human cells [21].
In summary, the natural compounds ellagic acid, propyl 
gallate and cinchonidine are identified as potentially useful 
sensitisers of E. coli carrying the pEK499 plasmid to anti-
biotics of several classes. Cepharanthine is also identified 
as a novel inhibitor of efflux in E. coli. In terms of potential 
for further discovery, the relatively fruitful ‘hit rate’ of the 
primary screen (~ 2%), also suggests that phytochemicals 
isolated from traditional medicines may be more rich in such 
compounds than previously appreciated. These molecules 
could have potential as scaffolds for the development of 
antibiotic resistance reversing drugs with favourable safety 
profiles.
3  Experimental Section
3.1  General Experimental Procedures
Escherichia coli NCTC 13400 (Public Health England) was 
selected for study as it displays resistance to eight different 
classes of antibiotic, via carriage of the pEK-499 plasmid, 
which contains ten resistance genes of well-established func-
tion [17]. The pEK-499 plasmid is also a common cause of 
antibiotic resistance in urinary tract infections in the UK 
[17]. The control strain, lacking resistance to the tested anti-
biotics, was E. coli DH5-α. The phytochemical library used 
(Puretitre library, Caithness Biotechnologies, UK) com-
prises 200 compounds of natural origin, and was chosen for 
screening as it comprises only compounds with a history of 
either safe oral use in man, or as a component of a traditional 
herb or medicine.
3.2  Primary Screen for Phytochemicals 
with Capacity to Reverse Resistance 
to Tetracycline
Tetracycline was used as the model antibiotic in the pri-
mary screen, as the focus of this study was on non-lactamase 
based resistance mechanisms, and because pEK-499 con-
fers a 32-fold increase in minimum inhibitory concentra-
tion (MIC) for tetracycline in E. coli strain J53, via expres-
sion of the tet(A) gene [17]. An overnight culture of E. coli 
NCTC 13400 was used to inoculate a test culture to a density 
of ~ 4 × 105 cells/mL in Luria broth (LB) supplemented with 
16 μg/mL tetracycline, equivalent to one quarter of the MIC 
for this antibiotic in this strain. 180 μL of this suspension 
was then plated in 96-well plates, and 20 μL of each natu-
ral compound (at 1 mM with 32 μg/mL tetracycline) was 
added to each well for a final concentration of 100 μM. 8 
wells per plate were used as vehicle controls (1% dimethyl 
sulphoxide, DMSO). Plates were then incubated at 37 °C, 
and absorbance at 600 nm was measured at 0, 5, 8 and 21 h 
using a microplate reader (Tecan). All values were corrected 
for baseline absorbance by subtraction of the value measured 
at t = 0 to account for the potential impact of test compounds 
on absorbance at 600 nm.
Two scores were used to rank the effectiveness of the 
test compounds in the primary screen. The first score was 
calculated as the ratio of growth rate between 0 and 5 h with 
tetracycline to growth rate over the same period without tet-
racycline. The second score was calculated as the ratio of the 
growth rate between 5 and 8 h in the presence and absence 
of tetracycline. The sum of the two scores was then used for 
the final ranking. Existing antibiotics were removed from the 
list, and the top four remaining hits were taken forward for 
replication and further studies.
3.3  Checkerboard Assays and Measurement 
of Growth Kinetics
The broth microdilution method was used, with doubling 
dilutions of compound and each antibiotic of interest 
arranged across a 96-well microplate in a total volume of 
150 μL. Plates were incubated at 37 °C, and absorbance 
at 600 nm was measured at 0, 5, 8 and 21 h using a micro-
plate reader (Tecan). For measurement of growth kinetics in 
the absence of antibiotics, bacteria were plated with 64 μM 
of each phytochemical (or 16 μM each for the mixtures), 
and cultured at 37 °C with measurements of absorbance at 
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600 nm every hour to 8 h post plating, and also at 10 and 
24 h. Baseline (t = 0) absorbance was subtracted from each 
value to account for pigments associated with the phyto-
chemicals or mixtures. As the hit phytochemicals alone 
were unable to prevent growth of E. coli even at the maxi-
mum practicable concentration (1 mM), MICs could not be 
calculated for these compounds, and therefore fractional 
inhibitory concentration index (FICI) values could not be 
determined.
3.4  Bacterial Accumulation and Efflux Assays
Nile red was used as a marker of cellular uptake and efflux in 
these experiments, as it is a substrate for the E. coli AcrAB-
TolC efflux system, its polarity is similar to that of many 
antibiotics and its entry to and exit from the bacterial cell 
can be conveniently monitored by changes in fluorescence. 
The method of Bohnert et al. was used, with the follow-
ing modifications [14]. 1.4 mL of an overnight culture of 
E. coli NCTC 13400 was pelleted (4000g for 5 min), then 
resuspended in phosphate buffered saline (PBS) with 1 mM 
 MgCl2 (PBS-M) to an absorbance at 600 nm of 1.0. For 
accumulation assays, 200 μL of this suspension was plated 
directly into each well of a 96-well microtitre plate, and phy-
tochemicals were added to a concentration of 64 μM (16 μM 
of each compound for the mixtures). Fluorescence values for 
each well were then measured every 5 s for 2 min using exci-
tation of 544 nm and emission of 620 ± 10 nm with a fluores-
cence microplate reader (Fluostar Omega, BMG Labtech). 
20 μL of Nile red stock (1 mM) was then injected into each 
well to a concentration of 5 μM. Fluorescence values were 
then measured every 5 s for 40 min. For efflux assays, bacte-
rial suspensions were prepared in PBS-M as above, but were 
first supplemented with 10 μM carbonyl cyanide m-chloro-
phenylhydrazone (CCCP, to de-energise cells and halt efflux) 
for 15 min, before addition of Nile red stock to a concen-
tration of 5 μM. After 3 h incubation at room temperature, 
cells were pelleted (4000g for 5 min), resuspended in 1.4 mL 
PBS-M, plated at 200 μL per well, and supplemented with 
phytochemicals as above. Fluorescence values were meas-
ured every 5 s for 2 min. Each well was then supplemented 
with glucose (to 50 mM) to re-energise the cells and restart 
efflux, and fluorescence measurements were immediately 
resumed for a further 40 min.
3.5  Mammalian Cell Viability Assays
The HEK-293 cell-line was chosen as a model cell-line to 
investigate the potential toxicity of the hit compounds in 
mammalian systems because it is human, not of tumour ori-
gin (it is virally transformed), and commonly used to test the 
effects of new compounds on cell viability [22]. Cells were 
cultured in Dulbecco’s Modified Eagles Medium (DMEM) 
with 10% serum and plated at 2 × 104 cells per well of 
96-well plates. After 24 h of culture, cells were challenged 
with phytochemicals at concentrations from 0.5 to 128 μM, 
or vehicle control (equivalent concentration of DMSO). Cell 
viability was then measured 24 h later by 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, 
as described previously [23].
3.6  Statistical Analyses
One-way ANOVA with Dunnett’s post-hoc test was used 
to compare the means of test conditions with those of the 
control condition.  IC50 values, and assessment of potential 
significance of differences between dose curves, were cal-
culated using GraphPad Prism. Differences were assumed 
to be significant at P < 0.05.
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